Modafinil is a eugeroic drug initially developed in the 1970s by French pharmaceutical company Lafon Laboratories as a treatment for narcolepsy. It promotes wakefulness by influencing neurotransmitters such as dopamine, histamine, and orexin. Unlike traditional stimulants, it has a low risk of dependency and minimal side effects, making it popular for managing sleep disorders, shift work sleep disorder, and excessive daytime sleepiness. Modafinil is also used off-label to enhance cognitive performance and focus, though such uses are not medically approved.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Modafinil 200 by Pharmaceutical Grade, consult with your doctor or healthcare professional.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.